SESSION TITLE: Fellow Case Report Poster - Obstructive Lung Disease
SESSION TYPE: Affiliate Case Report Poster
PRESENTED ON: Tuesday, October 25, 2016 at 01:30 PM - 02:30 PM
INTRODUCTION: Pulmonary Arterial hypertension (PAH) is a progressive disease confers a poor prognosis, often leading to right ventricular failure and death. Prostacyclin infusion is Class IA recommendation for the treatment of patients with NYHA FC III and IV symptoms. Despite its pivotal role in management, patients often find it onerous as administration is complex, requiring central venous access, and small errors in administration can be life-threatening. Transition off of parenteral therapy to oral or inhaled agents is often a patient goal, but can be difficult to achieve.